Anmeldung erfolgt in Kürze...
Details werden geladen...
Delhi HC directs Sun Pharma to take permission before launching semaglutide | Company Business News
Delhi High Court ordered Sun Pharma to seek judicial approval before launching semaglutide tablets, following a patent infringement suit by Novo Nordisk. The order requires Sun Pharma to return to court once it secures a manufacturing licence.
Ähnliche Seiten
Sun will require HC nod for Semaglutide tablet launch - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-will-require-hc-nod-for-semaglutide-tablet-launch/articleshow/133164615.cms